Allergan Q1 U.S. specialized therapeutics revenue down 2.3% to $1.54 bln; FactSet consensus $1.52 bln
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

from MarketWatch.com - Real-time Headlines https://on.mktw.net/TTxzoZ
via IFTTT
from MarketWatch.com - Real-time Headlines https://on.mktw.net/TTxzoZ
via IFTTT
Kommentare
Kommentar veröffentlichen